| abstract |
The present invention is directed to compounds having the formula (I): n nuseful in treating inflammatory and immune diseases, in which K and L are independently, O or S; Q is —C(═O)— or optionally substituted C 1-6 alkylene; Ar is optionally-substituted aryl or heteroaryl; J 1 , J 2 , J 3 and Y are selected so that ring A is a five-to-six membered optionally-substituted cycloalkenyl or heterocyclo ring having 0 to 2 nitrogen heteroatoms; R 1 is N or C(R 9 ); and R 2 , and R 3 , are as defined in the specification. |